Sarah Pett | |
|---|---|
| Alma mater | University of Edinburgh |
| Scientific career | |
| Fields | Immunopathology |
| Institutions | University of New South Wales University College London |
Sarah L. Pett is a Professor of Infectious Diseases at University College London. Pett is interested in the immunopathology of infections and the development of optimised treatment pathways for infections. During the COVID-19 pandemic, Pett led a clinical trial that investigated the efficacy of remdesivir as a treatment for coronavirus disease.[1]